LEIDEN, September 8, 2022 – MIMETAS, a global leader in organ-on-chip-based disease models for drug discovery and development, has appointed Dhaval Patel as Chair of its Board of Directors.
Dhaval Patel is Executive Vice President and Chief Scientific Officer at UCB, Belgium, clinical professor at the University of North Carolina Chapel Hill, and former Head of Research for the Novartis Institutes for BioMedical Research Europe.
{iframe}https://www.mimetas.com/en/news/586/mimetas-appoints-dhaval-patel-as-chair-of-the-board-of-directors.html{/iframe}